{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:02:36Z","timestamp":1768294956512,"version":"3.49.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1981,1,1]],"date-time":"1981-01-01T00:00:00Z","timestamp":347155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":14152,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1981]]},"DOI":"10.1016\/s0021-5198(19)52782-2","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T04:55:43Z","timestamp":1605675343000},"page":"1043-1050","source":"Crossref","is-referenced-by-count":22,"title":["POSSIBLE MECHANISMS OF THE TRIPHASIC EFFECTS OF NEUROTENSIN ON THE RAT BLOOD PRESSURE"],"prefix":"10.1016","volume":"31","author":[{"given":"Mariko","family":"OISHI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiyoko","family":"INAGAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motokazu","family":"FUJIWARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"TAKAORI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruaki","family":"YAJIMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"AKAZAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0021-5198(19)52782-2_bib1","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1016\/S0021-9258(19)43429-7","article-title":"The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami","volume":"248","author":"Carraway","year":"1973","journal-title":"J. biol. Chem."},{"key":"10.1016\/S0021-5198(19)52782-2_bib2","series-title":"Peptides: Chemistry, Structure and Biology, Proc. 4th Amer. Pept. Symp.","first-page":"679","article-title":"Structural requirements for the biological activity of neurotensin, a new vasoactive peptide","author":"Carraway","year":"1975"},{"key":"10.1016\/S0021-5198(19)52782-2_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1748-1716.1976.tb10340.x","article-title":"Cardiovascular and metabolic actions of neurotensin and (Gln4)-neurotensin","volume":"98","author":"Rosell","year":"1976","journal-title":"Acta physiol. scand."},{"key":"10.1016\/S0021-5198(19)52782-2_bib4","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/0024-3205(79)90600-3","article-title":"Increased sensitivity to neurotensin in fasted rats","volume":"25","author":"Quirion","year":"1979","journal-title":"Life Sci."},{"key":"10.1016\/S0021-5198(19)52782-2_bib5","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/0024-3205(80)90435-X","article-title":"Compound 48\/80 inhibits neurotensin-induced hypotension in rats","volume":"27","author":"Quirion","year":"1980","journal-title":"Life Sci."},{"key":"10.1016\/S0021-5198(19)52782-2_bib6","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1248\/cpb.23.3299","article-title":"Studies on peptides. Application of trifluoromethanesulphonic acid as a deblocking reagent to the synthesis of neurotensin","volume":"23","author":"Yajima","year":"1975","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/S0021-5198(19)52782-2_bib7","first-page":"169","article-title":"Studies on peptides","volume":"14","author":"Yajima","year":"1979","journal-title":"LXXXI. Application of a new arginine derivative, NG\u2212mesitylene-2-sulfonylarginine, to the synthesis of substance P and neurotensin. Int. J. Peptide Protein Res."},{"key":"10.1016\/S0021-5198(19)52782-2_bib8","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1113\/jphysiol.1953.sp004917","article-title":"Reduction of tissue histamine by compound 48\/80","volume":"120","author":"Feldberg","year":"1953","journal-title":"J. Physiol."},{"key":"10.1016\/S0021-5198(19)52782-2_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2337\/diab.27.5.577","article-title":"Neurotensin hyperglycemia: Evidence for histamine mediation and the assessment of a possible physiologic role","volume":"27","author":"Nagai","year":"1978","journal-title":"Diabetes"},{"key":"10.1016\/S0021-5198(19)52782-2_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1210\/endo-100-3-751","article-title":"Effect of neurotensin, substance P and morphine sulfate on the secretion of prolactin and growth hormone in the rat","volume":"100","author":"Rivier","year":"1977","journal-title":"Endocrinology"},{"key":"10.1016\/S0021-5198(19)52782-2_bib11","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1016\/S0021-9258(19)66951-6","article-title":"Mast cell binding of neurotensin. I. lodination of neurotensin and characterization of the interaction of neurotensin with mast cell receptor sites","volume":"252","author":"Lazarus","year":"1977","journal-title":"J. biol. Chem."},{"key":"10.1016\/S0021-5198(19)52782-2_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00365528009181500","article-title":"The in vitro effect of neurotensin on human jejunal mast cells","volume":"15","author":"Selbekk","year":"1980","journal-title":"Scand. J. Gastroent."},{"key":"10.1016\/S0021-5198(19)52782-2_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(81)90469-6","article-title":"The hypotensive effect of centrally administered neurotensin in rats","volume":"69","author":"Rioux","year":"1981","journal-title":"Europ. J. Pharmacol."}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819527822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819527822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T10:42:23Z","timestamp":1669632143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819527822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981]]},"references-count":13,"aliases":["10.1254\/jjp.31.1043"],"journal-issue":{"issue":"6","published-print":{"date-parts":[[1981]]}},"alternative-id":["S0021519819527822"],"URL":"https:\/\/doi.org\/10.1016\/s0021-5198(19)52782-2","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1981]]}}}